Browse studies, page 1106
Page 1106 of 1,183, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Correlations between metformin and prognosis and adverse reactions in patients undergoing radical cystectomy followed by adjuvant GC chemotherapy for bladder cancer BMC cancer, 2026
- Safety and efficacy of metformin for the treatment of pain: protocol for a systematic review BMJ open, 2026
- Association Between Oral Antihyperglycemic Medications and Erectile Function in Men with Type 2 Diabetes Mellitus Life (Basel, Switzerland), 2026
- CGM-based metrics and mortality in older adults living with type 2 diabetes on insulin therapy: a secondary analysis of the HYPOAGE study Diabetes & metabolism, 2026
- Disease-modifying anti-diabetic drugs (DMADDs): bridging the SIMPLE approach to disease interception Cardiovascular diabetology, 2026
- Comparative efficacy and safety of finerenone in diabetic kidney disease: a meta-analysis of Asian and non-Asian populations BMC nephrology, 2025
- SGLT2 inhibitor role in cardio-metabolic-renal diseases: a narrative review of recent evidence and their pharmacological, clinical and economic implications Drugs in context, 2026
- Targeting a hypothetical estimand based on adherence with the parametric g-formula: A post hoc secondary analysis of the MET-PREVENT randomised controlled trial medRxiv, 2025
- Empagliflozin and its impact on hepatic and metabolic outcomes in patients with type 2 diabetes and NAFLD: a systematic review and meta-analysis Diabetology & metabolic syndrome, 2026
- Effects of Metformin Monotherapy Versus Metformin Plus SGLT-2 Inhibitor Therapy on Molecular and Cellular Inflammatory Markers in Patients with Newly Diagnosed Type 2 Diabetes Mellitus Journal of clinical medicine, 2026
- Clinical and Dermoscopic Evaluation of the Effectiveness of Metformin versus Pioglitazone in Acanthosis Nigricans: A Randomised Controlled Trial Indian dermatology online journal, 2026
- The effects of metformin and exercise training on cardiorespiratory, blood pressure, and metabolic adaptations across the spectrum of glucose dysregulation: a systematic review and meta-analysis EClinicalMedicine, 2026
- Tirzepatide as an Add-on for Participants with Inadequate Glycemic Control Using Basal Insulin: Pooled Subgroup Analysis of SURPASS-5 and -6 Diabetes therapy : research, treatment and education of diabetes and related disorders, 2026
- Current Insights and Future Directions on the Role of GLP-1 Receptor Agonists in Chronic Kidney Disease International journal of nephrology and renovascular disease, 2026
- Long-term stability of the triglyceride-glucose index in cancer patient Cohort Scientific reports, 2026
- Taurine reduces intracellular glucose accumulation in fructose-treated Caenorhabditis elegans Amino acids, 2026
- Betanin Modulates the Leptin-Adiponectin Axis and Improves Glycemic Control in a High-Fat Diet and Streptozotocin-Induced Rat Model of Type 2 Diabetes Cureus, 2026
- Immunological Drug-Drug Interactions in Immune Checkpoint Inhibitor Therapy: Mechanisms, Clinical Evidence, and Artificial Intelligence Current oncology reports, 2026
- Beyond cardiovascular protection: a conceptual and translational review of the hepato-specific mechanisms of statins in metabolic dysfunction-associated steatotic liver disease (MASLD) Frontiers in pharmacology, 2026
- Efficacy and Safety of iGlarLixi Versus IDegAsp by Baseline Age, Disease Duration and HbA1c in Chinese People With Type 2 Diabetes: Post Hoc Analyses of the Soli-D Study Diabetes, obesity & metabolism, 2026
- Withholding or continuing glucose-lowering drugs for elective surgery in patients with type 2 diabetes mellitus: a secondary analysis of the MOPED international, prospective, observational study British journal of anaesthesia, 2026
- Observational studies on the association of outpatient antidiabetic medication use and COVID-19 outcomes: are the findings more relevant to diabetes management than to COVID-19 pathology? A mini-review Frontiers in clinical diabetes and healthcare, 2026
- Mechanistic Insights Into the Cardioprotective Effects of Modern Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review Cureus, 2025
- Comparative risk of hepatocellular carcinoma and mortality among initiators of GLP-1 receptor agonists versus other glucose-lowering therapies: a target trial emulation Hepatology international, 2026
- Dorema Aucheri Extract Modulates Unfolded Protein Response Pathways in Streptozotocin-Induced Diabetic Rats: A Protective Role Against Hepatic Damage International journal of endocrinology, 2026
- Metformin and Hypertensive Disorders of Pregnancy: A Phenotype-Based Focused Narrative Review Journal of clinical medicine, 2026
- Comparative response to pharmacological management of asthma in overweight/obese children versus their counterparts: a systematic review and call for data European respiratory review : an official journal of the European Respiratory Society, 2026
- The Extent and Phenotype of Coronary Artery Disease in Diabetes and Prediabetes: Insights From Imaging Studies and Potential Therapeutic Implications Reviews in cardiovascular medicine, 2026
- Metformin and Flutamide Combination Therapy's Efficacy and Safety in Prostate Cancer Cell Lines Prostate cancer, 2026
- LAP-defined hepatic steatosis and cardiometabolic risk in rheumatoid arthritis: a post-hoc analysis of the FRANCIS randomized trial Rheumatology international, 2026
- Cardioprotective effect of diabetic medication on cancer patients undergoing proven cardiotoxic chemotherapy: a systematic review and meta-analysis Cardio-oncology (London, England), 2026
- Combination of GLP-1 receptor agonists and SGLT2 inhibitors in cardiometabolic disease: synergistic, additive, or non-additive effects? A narrative review Cardiovascular diabetology, 2026
- Glucagon-like peptide-1 receptor agonists and risk of depression: a systematic review and meta-analysis BMC psychiatry, 2026
- Effectiveness of GLP-1 Receptor Agonists in Patients With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomised Controlled Trials Cureus, 2026
- Circulating propionate and butyrate are associated with metabolic improvements following probiotic and dietary fiber supplementation in patients on antipsychotics: a post-hoc analysis of a randomized controlled trial BMC psychiatry, 2026
- Co-prescription of metformin and glucagon-like peptide-1 receptor agonists and metformin-associated lactic acidosis: A case series Clinical nephrology. Case studies, 2026
- CGM-derived postprandial glucose with IcoSema versus other insulin regimens: a post hoc analysis of COMBINE 1 and 3 EClinicalMedicine, 2026
- Meta-Analysis of the Effect of Metformin on the Progression of Different Types of Prediabetes Mellitus Diabetes, metabolic syndrome and obesity : targets and therapy, 2026
- Evidence of a Protective Effect of Metformin on Abdominal Aortic Aneurysm Risk: Insights From an Observational Study and Mendelian Randomisation Analysis Using Putative Metformin Targets Annals of human genetics, 2026
- Efficacy and safety of metformin versus empagliflozin on chronic kidney disease progression (MET-EMPA-CKD): a randomized controlled trial Diabetology & metabolic syndrome, 2025
- iGlarLixi: A titrateable fixed-ratio combination of basal insulin + GLP-1 receptor agonist-An effective type 2 diabetes treatment option in China Diabetes, obesity & metabolism, 2025
- Effects of Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors on Lipid Profiles in Type 2 Diabetes: A Systematic Review Cureus, 2026
- Impact of Semaglutide, Liraglutide and Tirzepatide on Cardiometabolic Outcomes: A Comparative Narrative Review Endocrinology, diabetes & metabolism, 2026
- Metabolic-Protective Strategies for Antipsychotic-Associated Weight Gain in Children and Adolescents: A Systematic Review Cureus, 2026
- Clinical characteristics of Sarcopenic obesity in Japanese people with type 2 diabetes: A post hoc analysis of the sub-cohort iDIAMOND study Journal of diabetes investigation, 2026
- Association of metformin with lung function decline and mortality in fibrotic interstitial lung disease: an observational cohort study Respiratory research, 2026
- Predictors of Initial and Sustained Glycemic and Weight Response to Tirzepatide: A Post Hoc Analysis of SURPASS-4 Diabetes, 2025
- Metformin and insulin exacerbate one-carbon metabolism deficits in pregnant growth restricted rats and impacts the placenta, fetal liver and pancreas The Journal of physiology, 2025
- 11-Oxygenated Androgens in Pcos: Impact of Pcos Phenotypes and First-Line Interventions The Journal of clinical endocrinology and metabolism, 2026
- Evaluating Cost-Effectiveness in Relation to the Supporting Clinical Evidence Across the Type 2 Diabetes Continuum: A Review of Metformin and SGLT2is Advances in therapy, 2026
- Annual pharmacy cost per patient achieving composite treatment endpoints: a cost to target analysis of tirzepatide versus subcutaneous semaglutide 1 mg in patients with type 2 diabetes in the UK. Journal of medical economics, 2026
- Safety and Efficacy of Glucagon-Like Peptide-1 Receptor Agonists Use in Elderly People With Obesity-A Meta-Analysis Obesity (Silver Spring, Md.), 2026
- Fenofibrate Protects Against Antipsychotic-Induced Hyperglycemia Through Weight Loss and FGF21 Dependent Mechanisms FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026
- Metformin Exposure in Pregnancy and Fetal Programming: A Focused Review of Contemporary Evidence Biomedicines, 2026
- A Real-World Cohort Study on the Association of the Use of Sodium-Glucose Cotransporter-2 Inhibitor With the Incidence of Chronic Kidney Disease (CKD) in Patients With Type 2 Diabetes Mellitus Without CKD Using the SingHealth Diabetes Registry Diabetes, obesity & metabolism, 2026
- Metformin alleviates diastolic dysfunction in mice with experimental diabetic cardiomyopathy Journal of molecular and cellular cardiology plus, 2025
- Imeglimin-Associated Temporal Changes in γ-Glutamyl Transferase and Total Cholesterol: A Post Hoc Exploratory Analysis of the INFINITY Study Journal of personalized medicine, 2026
- Mycobacterium tuberculosis diversity and macrophage heterogeneity dictate phagosomal acidification Microbiology spectrum, 2026
- Imeglimin Treatment May Improve Whole-Blood Fluidity and Influence Hemorheology in Patients with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the INFINITY Study Journal of personalized medicine, 2026
- Circulating GDF15 and HbA1c Response to Add-On Exenatide Therapy in Type 2 Diabetes: A Post Hoc Analysis from a Multicenter Trial Biomedicines, 2026
- Obesity and Women's health across the lifespan: A clinical review of life Stage-Specific challenges and treatment considerations Obesity pillars, 2026
- Associations between the gut microbiome and diet, body composition, and glycemic profiles: a cross-sectional post-hoc analysis of the Personal Diet Study Frontiers in nutrition, 2026
- Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II Trials Cancer medicine, 2026
- Perivascular administration of metformin through 3D minichannels improved adventitia ingrowth and endothelialization for electrospinning vascular grafts Bioactive materials, 2026
- Glucagon-Like Peptide-1 Receptor Agonists: Their Potential Role in Prediabetes Diabetes therapy : research, treatment and education of diabetes and related disorders, 2026
- Systematic review of influence of ethnicity on efficacy and safety of pharmacotherapy for childhood and adolescent obesity Clinical and experimental pediatrics, 2026
- Ovulatory Recovery following weight loss in women with polycystic ovary syndrome and obesity: a post hoc analysis of the BAMBINI randomised controlled trial Human reproduction (Oxford, England), 2026
- Plasma metformin concentration as a determinant of metabolic response in adults with type 1 diabetes: a 1-year prospective observational study Frontiers in pharmacology, 2026
- A comparison of glycaemic effects of sitagliptin and sulfonylureas in elderly patients with type 2 diabetes mellitus International journal of clinical practice, 2015
- Improving diabetes prevention with benefit based tailored treatment: risk based reanalysis of Diabetes Prevention Program BMJ (Clinical research ed.), 2015
- Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus from Latin America Current medical research and opinion, 2016
- Testosterone and depressive symptoms among men in the Diabetes Prevention Program Psychoneuroendocrinology, 2016
- Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus living in hot climates International journal of clinical practice, 2016
- Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: Latin American subpopulation analysis of a randomized trial Diabetology & metabolic syndrome, 2016
- Impact of bromocriptine-QR therapy on cardiovascular outcomes in type 2 diabetes mellitus subjects on metformin Postgraduate medicine, 2016
- Associations between changes in glucagon-like peptide-1 and bodyweight reduction in patients receiving acarbose or metformin treatment Journal of diabetes, 2017
- Quality measure attainment with dapagliflozin plus metformin extended-release as initial combination therapy in patients with type 2 diabetes: a post hoc pooled analysis of two clinical studies Risk management and healthcare policy, 2016
- Effects of Metformin and a Mammalian Target of Rapamycin (mTOR) ATP-Competitive Inhibitor on Targeted Metabolomics in Pancreatic Cancer Cell Line Metabolomics : open access, 2016
- Efficacy and Safety of IDegLira in Participants with Type 2 Diabetes in India Uncontrolled on Oral Antidiabetic Drugs and Basal Insulin: Data from the DUAL Clinical Trial Program Diabetes therapy : research, treatment and education of diabetes and related disorders, 2017
- Continuation of non-essential medications in actively dying hospitalised patients BMJ supportive & palliative care, 2017
- Safety and efficacy of the combination of the glucagon-like peptide-1 receptor agonist liraglutide with an oral antidiabetic drug in Japanese patients with type 2 diabetes: Post-hoc analysis of a randomized, 52-week, open-label, parallel-group trial Journal of diabetes investigation, 2018
- Effectiveness of Vildagliptin in Clinical Practice: Pooled Analysis of Three Korean Observational Studies (the VICTORY Study) Journal of diabetes research, 2017
- Fetal Growth and Birth Anthropometrics in Metformin-Exposed Offspring Born to Mothers With PCOS. The Journal of clinical endocrinology and metabolism, 2018
- Association between insulin resistance and preeclampsia in obese non-diabetic women receiving metformin Obstetric medicine, 2017
- Metformin Does Not Affect Clinically Relevant Outcomes in Patients with Idiopathic Pulmonary Fibrosis Respiration; international review of thoracic diseases, 2018
- Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with premixed insulin Diabetes, obesity & metabolism, 2019
- Effect of vitamin D supplementation on cardiovascular risk in type 2 diabetes Clinical nutrition (Edinburgh, Scotland), 2019
- Statins are Associated With Increased Biochemical Recurrence After Radical Prostatectomy in Diabetic Men but no Association was Seen in Men also Taking Metformin: Results From the SEARCH Database Clinical genitourinary cancer, 2019
- Weight loss in patients with type 2 diabetes receiving once-weekly dulaglutide plus insulin lispro or insulin glargine plus insulin lispro: A post-hoc analysis of the AWARD-4 study across baseline body mass index subgroups Diabetes, obesity & metabolism, 2019
- Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer's disease: Pooled analysis from 5 cohorts PloS one, 2019
- Baseline nocturnal glucose change: A predictor of the treatment effect of bolus intensification in insulin-treated type 2 diabetes Diabetes, obesity & metabolism, 2019
- Incidence and risk factors for hyperlactatemia in ED patients with acute metformin overdose The American journal of emergency medicine, 2019
- Efficacy and safety of iglarlixi in hispanics and NON-hispanic whites with type 2 diabetes. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2019
- Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes Diabetes, obesity & metabolism, 2020
- Beta cell function and insulin sensitivity in obese youth with maturity onset diabetes of youth mutations vs type 2 diabetes in TODAY: Longitudinal observations and glycemic failure Pediatric diabetes, 2020
- Once-Weekly Semaglutide Reduces HbA1c and Body Weight in Patients with Type 2 Diabetes Regardless of Background Common OAD: a Subgroup Analysis from SUSTAIN 2-4 and 10 Diabetes therapy : research, treatment and education of diabetes and related disorders, 2020
- Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease Diabetes therapy : research, treatment and education of diabetes and related disorders, 2020
- iGlarLixi effectively reduces residual hyperglycaemia in patients with type 2 diabetes on basal insulin: A post hoc analysis from the LixiLan-L study Diabetes, obesity & metabolism, 2020
- Effects of dipeptidyl peptidase-4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis of an 8-week, randomized, controlled, double-blind trial Diabetes, obesity & metabolism, 2020
- Impact of Concomitant Medications on Biochemical Outcome in Localised Prostate Cancer Treated with Radiotherapy and Androgen Deprivation Therapy Clinical oncology (Royal College of Radiologists (Great Britain)), 2021
